Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
Etoposide (VP16) is the traditional antitumor agent which has been widely used in a variety of cancers. However, intravenous administration of VP16 was limited in clinical application because of its low aqueous solubility, poor bioavailability and dose-limiting adverse effects. Local chemotherapy wi...
Saved in:
Main Authors: | Chunsheng Wu (Author), Xiangting Yi (Author), Renzhi Xu (Author), Maokuan Zhang (Author), Yan Xu (Author), Yan Ma (Author), Li Gao (Author), Zhengbao Zha (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhanced tumor uptake, biodistribution and pharmacokinetics of etoposide loaded nanoparticles in Dalton's lymphoma tumor bearing mice
by: Movva Snehalatha, et al.
Published: (2013) -
Characterization and antitumor efficacy of poly(L-lactid acid)-based etoposide-loaded implants
by: Li Gao, et al.
Published: (2017) -
Photochemical Internalization of Etoposide Using Dendrimer Nanospheres Loaded with Etoposide and Protoporphyrin IX on a Glioblastoma Cell Line
by: Martin Hsiu-Chu Lin, et al.
Published: (2021) -
Etoposide Therapy for Recurrent Gliomas
by: J Gordon Millichap
Published: (1997) -
Occupational rhinosinusitis due to etoposide, an antineoplastic agent
by: Harald W Meyer, et al.
Published: (2010)